Huntington Ingalls Industries Inc
Change company Symbol lookup
Select an option...
HII Huntington Ingalls Industries Inc
BABA Alibaba Group Holding Ltd
ABBV Abbvie Inc
OBMP OncBioMune Pharmaceuticals Inc
AVNW Aviat Networks Inc
AMPY Amplify Energy Corp
JEPI JPMorgan Equity Premium Income ETF
AGNC Agnc Investment Corp
GME GameStop Corp

Industrials : Aerospace & Defense | Mid Cap Value
Company profile

Huntington Ingalls Industries, Inc. is a military shipbuilding company and a provider of professional services to partners in government and industry. The Company's business consists of the design, construction, repair and maintenance of nuclear-powered ships and non-nuclear ships for the United States Navy and coastal defense surface ships for the United States Coast Guard, as well as the refueling and overhaul and inactivation of nuclear-powered ships for the United States Navy. It operates through three segments: Ingalls Shipbuilding (Ingalls), Newport News Shipbuilding (Newport News) and Technical Solutions. Its Ingalls segment includes its non-nuclear ship design, construction, repair and maintenance businesses. Its Newport News includes all of its nuclear ship design, construction, overhaul, refueling, and repair and maintenance businesses. Its Technical Solutions segment provides a range of professional services to the governmental and energy markets.

Closing Price
Day's Change
-0.29 (-0.14%)
B/A Size
Day's High
Day's Low

10-day average volume:

Zomedica stock tumbles on heavy volume after public stock offering upsized 7-fold 'due to demand'

8:16 am ET February 9, 2021 (MarketWatch)

Shares of Zomedica Corp. (ZOM) tumbled 17.0% in premarket trading Tuesday, after the veterinary health company's common stock offering, that was upsized by nearly seven-fold, priced at a deep discount. Trading volume of 40.1 million shares made Zomedica's stock the most actively traded ahead of the open. The company said overnight that the sole book-running manager for the offering, H.C. Wainwrite & Co. agreed to increase the size of the public offering "due to demand" to 91.3 million shares at a price of $1.90 to raise $173.5 million. The offering represented 16.2% of the 564.1 million shares outstanding as of Nov. 11, while the offering price was 29.6% below Monday's closing price of $2.70. Originally late Monday, Zomedica had announced an offering of 13.16 million shares to raise $25.0 million. Zomedica's upsized offering comes after the stock skyrocketed 1,070.9% year to date through Monday, compared with the S&P 500's 4.3% gain over the same time.

-Tomi Kilgore; 415-439-6400;


(END) Dow Jones Newswires

February 09, 2021 08:16 ET (13:16 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.